Glucagon Drug Market - Global Outlook and Forecast 2022-2028

March 2022 | 72 pages | ID: G8D9D520E9F5EN
Market Monitor Global

Abstracts

Glucagon is a prescription drug for injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.

This report contains market size and forecasts of Glucagon Drug in global, including the following market information:

Global Glucagon Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Glucagon Drug Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Glucagon Drug companies in 2021 (%)

The global Glucagon Drug market was valued at 572.1 million in 2021 and is projected to reach US$ 844.6 million by 2028, at a CAGR of 5.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Inject Glucagon Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glucagon Drug include Novo Nordisk, Eli Lilly, Fresenius Kabi and Torrent Labs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucagon Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glucagon Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glucagon Drug Market Segment Percentages, by Type, 2021 (%)

• Inject Glucagon
• Nasal Glucagon

Global Glucagon Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glucagon Drug Market Segment Percentages, by Application, 2021 (%)

• Emergency Kits
• General Use
• Diagnostic & Motility
• Cardiogenic Shock
• Others

Global Glucagon Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glucagon Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glucagon Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Glucagon Drug revenues share in global market, 2021 (%)

Key companies Glucagon Drug sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Glucagon Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• Eli Lilly
• Fresenius Kabi
• Torrent Labs

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glucagon Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Glucagon Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLUCAGON DRUG OVERALL MARKET SIZE

2.1 Global Glucagon Drug Market Size: 2021 VS 2028
2.2 Global Glucagon Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Glucagon Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Glucagon Drug Players in Global Market
3.2 Top Global Glucagon Drug Companies Ranked by Revenue
3.3 Global Glucagon Drug Revenue by Companies
3.4 Global Glucagon Drug Sales by Companies
3.5 Global Glucagon Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Glucagon Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Glucagon Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glucagon Drug Players in Global Market
  3.8.1 List of Global Tier 1 Glucagon Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Glucagon Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Glucagon Drug Market Size Markets, 2021 & 2028
  4.1.2 Inject Glucagon
  4.1.3 Nasal Glucagon
4.2 By Type - Global Glucagon Drug Revenue & Forecasts
  4.2.1 By Type - Global Glucagon Drug Revenue, 2017-2022
  4.2.2 By Type - Global Glucagon Drug Revenue, 2023-2028
  4.2.3 By Type - Global Glucagon Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Glucagon Drug Sales & Forecasts
  4.3.1 By Type - Global Glucagon Drug Sales, 2017-2022
  4.3.2 By Type - Global Glucagon Drug Sales, 2023-2028
  4.3.3 By Type - Global Glucagon Drug Sales Market Share, 2017-2028
4.4 By Type - Global Glucagon Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glucagon Drug Market Size, 2021 & 2028
  5.1.2 Emergency Kits
  5.1.3 General Use
  5.1.4 Diagnostic & Motility
  5.1.5 Cardiogenic Shock
  5.1.6 Others
5.2 By Application - Global Glucagon Drug Revenue & Forecasts
  5.2.1 By Application - Global Glucagon Drug Revenue, 2017-2022
  5.2.2 By Application - Global Glucagon Drug Revenue, 2023-2028
  5.2.3 By Application - Global Glucagon Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Glucagon Drug Sales & Forecasts
  5.3.1 By Application - Global Glucagon Drug Sales, 2017-2022
  5.3.2 By Application - Global Glucagon Drug Sales, 2023-2028
  5.3.3 By Application - Global Glucagon Drug Sales Market Share, 2017-2028
5.4 By Application - Global Glucagon Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glucagon Drug Market Size, 2021 & 2028
6.2 By Region - Global Glucagon Drug Revenue & Forecasts
  6.2.1 By Region - Global Glucagon Drug Revenue, 2017-2022
  6.2.2 By Region - Global Glucagon Drug Revenue, 2023-2028
  6.2.3 By Region - Global Glucagon Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Glucagon Drug Sales & Forecasts
  6.3.1 By Region - Global Glucagon Drug Sales, 2017-2022
  6.3.2 By Region - Global Glucagon Drug Sales, 2023-2028
  6.3.3 By Region - Global Glucagon Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Glucagon Drug Revenue, 2017-2028
  6.4.2 By Country - North America Glucagon Drug Sales, 2017-2028
  6.4.3 US Glucagon Drug Market Size, 2017-2028
  6.4.4 Canada Glucagon Drug Market Size, 2017-2028
  6.4.5 Mexico Glucagon Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Glucagon Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Glucagon Drug Sales, 2017-2028
  6.5.3 Germany Glucagon Drug Market Size, 2017-2028
  6.5.4 France Glucagon Drug Market Size, 2017-2028
  6.5.5 U.K. Glucagon Drug Market Size, 2017-2028
  6.5.6 Italy Glucagon Drug Market Size, 2017-2028
  6.5.7 Russia Glucagon Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Glucagon Drug Market Size, 2017-2028
  6.5.9 Benelux Glucagon Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Glucagon Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Glucagon Drug Sales, 2017-2028
  6.6.3 China Glucagon Drug Market Size, 2017-2028
  6.6.4 Japan Glucagon Drug Market Size, 2017-2028
  6.6.5 South Korea Glucagon Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Glucagon Drug Market Size, 2017-2028
  6.6.7 India Glucagon Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Glucagon Drug Revenue, 2017-2028
  6.7.2 By Country - South America Glucagon Drug Sales, 2017-2028
  6.7.3 Brazil Glucagon Drug Market Size, 2017-2028
  6.7.4 Argentina Glucagon Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Glucagon Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Glucagon Drug Sales, 2017-2028
  6.8.3 Turkey Glucagon Drug Market Size, 2017-2028
  6.8.4 Israel Glucagon Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Glucagon Drug Market Size, 2017-2028
  6.8.6 UAE Glucagon Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novo Nordisk
  7.1.1 Novo Nordisk Corporate Summary
  7.1.2 Novo Nordisk Business Overview
  7.1.3 Novo Nordisk Glucagon Drug Major Product Offerings
  7.1.4 Novo Nordisk Glucagon Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Novo Nordisk Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Glucagon Drug Major Product Offerings
  7.2.4 Eli Lilly Glucagon Drug Sales and Revenue in Global (2017-2022)
  7.2.5 Eli Lilly Key News
7.3 Fresenius Kabi
  7.3.1 Fresenius Kabi Corporate Summary
  7.3.2 Fresenius Kabi Business Overview
  7.3.3 Fresenius Kabi Glucagon Drug Major Product Offerings
  7.3.4 Fresenius Kabi Glucagon Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Fresenius Kabi Key News
7.4 Torrent Labs
  7.4.1 Torrent Labs Corporate Summary
  7.4.2 Torrent Labs Business Overview
  7.4.3 Torrent Labs Glucagon Drug Major Product Offerings
  7.4.4 Torrent Labs Glucagon Drug Sales and Revenue in Global (2017-2022)
  7.4.5 Torrent Labs Key News

8 GLOBAL GLUCAGON DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Glucagon Drug Production Capacity, 2017-2028
8.2 Glucagon Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Glucagon Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 GLUCAGON DRUG SUPPLY CHAIN ANALYSIS

10.1 Glucagon Drug Industry Value Chain
10.2 Glucagon Drug Upstream Market
10.3 Glucagon Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Glucagon Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Glucagon Drug in Global Market
Table 2. Top Glucagon Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Glucagon Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Glucagon Drug Revenue Share by Companies, 2017-2022
Table 5. Global Glucagon Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Glucagon Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Glucagon Drug Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Glucagon Drug Product Type
Table 9. List of Global Tier 1 Glucagon Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glucagon Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glucagon Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Glucagon Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Glucagon Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Glucagon Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Glucagon Drug Sales (K Units), 2023-2028
Table 16. By Application – Global Glucagon Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Glucagon Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Glucagon Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Glucagon Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Glucagon Drug Sales (K Units), 2023-2028
Table 21. By Region – Global Glucagon Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Glucagon Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Glucagon Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Glucagon Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Glucagon Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Glucagon Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Glucagon Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Glucagon Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Glucagon Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Glucagon Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Glucagon Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Glucagon Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Glucagon Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Glucagon Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Glucagon Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Glucagon Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Glucagon Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Glucagon Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Glucagon Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Glucagon Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Glucagon Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Glucagon Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Glucagon Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Glucagon Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Glucagon Drug Sales, (K Units), 2023-2028
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Glucagon Drug Product Offerings
Table 48. Novo Nordisk Glucagon Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Eli Lilly Corporate Summary
Table 50. Eli Lilly Glucagon Drug Product Offerings
Table 51. Eli Lilly Glucagon Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Fresenius Kabi Corporate Summary
Table 53. Fresenius Kabi Glucagon Drug Product Offerings
Table 54. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Torrent Labs Corporate Summary
Table 56. Torrent Labs Glucagon Drug Product Offerings
Table 57. Torrent Labs Glucagon Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Glucagon Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global Glucagon Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Glucagon Drug Production by Region, 2017-2022 (K Units)
Table 61. Global Glucagon Drug Production by Region, 2023-2028 (K Units)
Table 62. Glucagon Drug Market Opportunities & Trends in Global Market
Table 63. Glucagon Drug Market Drivers in Global Market
Table 64. Glucagon Drug Market Restraints in Global Market
Table 65. Glucagon Drug Raw Materials
Table 66. Glucagon Drug Raw Materials Suppliers in Global Market
Table 67. Typical Glucagon Drug Downstream
Table 68. Glucagon Drug Downstream Clients in Global Market
Table 69. Glucagon Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Glucagon Drug Segment by Type
Figure 2. Glucagon Drug Segment by Application
Figure 3. Global Glucagon Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glucagon Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glucagon Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Glucagon Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glucagon Drug Revenue in 2021
Figure 9. By Type - Global Glucagon Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Glucagon Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Glucagon Drug Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Glucagon Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Glucagon Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Glucagon Drug Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Glucagon Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Glucagon Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Glucagon Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Glucagon Drug Sales Market Share, 2017-2028
Figure 19. US Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Glucagon Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Glucagon Drug Sales Market Share, 2017-2028
Figure 24. Germany Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Glucagon Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Glucagon Drug Sales Market Share, 2017-2028
Figure 33. China Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Glucagon Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Glucagon Drug Sales Market Share, 2017-2028
Figure 40. Brazil Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Glucagon Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Glucagon Drug Sales Market Share, 2017-2028
Figure 44. Turkey Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Glucagon Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Glucagon Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Glucagon Drug by Region, 2021 VS 2028
Figure 50. Glucagon Drug Industry Value Chain
Figure 51. Marketing Channels